Abstract:Heavy-atom-based photosensitizers usually exhibit shortened triplet-state lifetimes, which is not ideal for hypoxic tumor photodynamic therapy. Although several heavy-atom-free photosensitizers possess long triplet-state lifetimes, the clinical applicability is limited by their short excitation wavelengths, poor photon capture abilities, and intrinsically hydrophobic structures. Herein we developed a novel NIR heavy-atom-free photosensitizer design strategy by introducing sterically bulky and electron-rich moieties at the meso position of the pentamethine cyanine (Cy5) skeleton, which simultaneously enhanced intersystem crossing (ISC) and prolonged excited-state lifetime. We found that the 1O2 generation ability is directly correlated to the electron-donating ability of the meso substituent in cyanine, and the excited-state lifetime was simultaneously much elongated when the substituents were anthracene derivatives substituted at the 9-position. Our star compound, ANOMe-Cy5, exhibits intense NIR absorption, the highest 1O2 quantum yield (4.48-fold higher than Cy5), the longest triplet-state lifetime (9.80-fold longer than Cy5), and lossless emission intensity (nearly no change compared with Cy5). Such excellent photophysical properties coupled with its inherently cationic and hydrophilic nature enable the photosensitizer to realize photoablation of solid tumor and antitumor lung metastasis. This study highlights the design of a new generation of NIR photosensitizers for imaging-guided photodynamic cancer treatment.The Supporting Information is available free of charge at https://pubs.acs.org/doi/10.1021/jacs.1c06275.Detailed experimental conditions and methods, Scheme S1, and Figures S1–S39 (PDF)This article has not yet been cited by other publications.

A Silicon-Rhodamine-Based Heavy-Atom-Free Photosensitizer for Mitochondria-targeted Photodynamic Therapy

Bromopropylate Imidazoliumyl Substituted Silicon Phthalocyanine for Mitochondria-Targeting, Two-Photon Imaging Guided in Vitro Photodynamic Therapy

Rational design of type-I photosensitizer molecules for mitochondrion-targeted photodynamic therapy

Unusual Electron Donor-Acceptor Sequenced NIR AIEgen for Highly Efficient Mitochondria-Targeted Cancer Cell Photodynamic Therapy.

Biotin-modified Cyclometalated Iridium-Based Photosensitizers As Mitochondria-Targeted Theranostic Agents for Tumor Photodynamic Therapy in Vitro and in Vivo

Rational Design of a High-Performance Quinoxalinone-Based AIE Photosensitizer for Image-Guided Photodynamic Therapy.

Efficient type I and type II ROS generated aggregation-induced emission photosensitizer for mitochondria targeted photodynamic therapy

Dual-targeted and viscosity-sensitive infrared AIE photosensitizer based on tumor microenvironmental response for photodynamic cancer therapy

Self-Assembled Nanoparticles of Silicon (IV)-NO Donor Phthalocyanine Conjugate for Tumor Photodynamic Therapy in Red Light

An Aggregation-Induced Emission Photosensitizer with Efficient Singlet Oxygen Generation Capacity for Mitochondria Targeted Photodynamic Therapy

An Approach to Developing Cyanines with Simultaneous Intersystem Crossing Enhancement and Excited-State Lifetime Elongation for Photodynamic Antitumor Metastasis

Mitochondria-targeted cyclometalated iridium (III) complex for H2S-responsive intracellular redox regulation as potent photo-oxidation anticancer agent

Photosensitizer (ps)/polyhedral Oligomeric Silsesquioxane (Poss)-Crosslinked Nanohybrids for Enhanced Imaging-Guided Photodynamic Cancer Therapy.

Pyridine-Embedded Phenothiazinium Dyes As Lysosome-Targeted Photosensitizers for Highly Efficient Photodynamic Antitumor Therapy

Biotin-Functionalized Iridium-Based Nanoparticles As Tumor Targeted Photosensitizers for Enhanced Oxidative Damage in Tumor Photodynamic Therapy

Phototherapeutic applications of benzophenone-containing NIR-emitting photosensitizers based on different receptor modulations

Iridium(III) Complexes Decorated with Silicane-Modified Rhodamine: Near-Infrared Light-Initiated Photosensitizers for Efficient Deep-Tissue Penetration Photodynamic Therapy

Rationally designed near-infrared AIEgens photosensitizer for cell membrane-targeted photo-driven theranostics

Mitochondria-localized Iridium(iii) Complexes with Anthraquinone Groups As Effective Photosensitizers for Photodynamic Therapy under Hypoxia

Smart Tumor‐Cell‐Derived Microparticles Provide On‐Demand Photosensitizer Synthesis and Hypoxia Relief for Photodynamic Therapy

Near-infrared AIEgens with high singlet-oxygen yields for mitochondria-specific imaging and antitumor photodynamic therapy